Publications & Research Reports
Dr. M. Christopher Roebuck has authored 120+ publications & research reports over a 28+ year career in health economics—peer-reviewed articles in journals including Health Affairs, Medical Care, the American Economic Review, and The American Journal of Managed Care, alongside issue briefs, commissioned reports, and professional publications. The bibliography below is open access to browse: every entry links to its DOI or PubMed record where one exists, with no gate in the way.
The record is independently verifiable through his Google Scholar profile and ORCID record. A full curriculum vitae (PDF) is also available. If you would like a copy of a specific paper, use the Request Full Paper link beside any entry and we will respond within one business day. To discuss how this research applies to your question, see our health economics and outcomes research consulting services.
Peer-Reviewed Articles
2024
2023
Paul Fronstin, M. Christopher Roebuck, A. Mark Fendrick. The Cost Implications of the Braidwood Ruling for Enrollees and Plan Sponsors. Health Affairs Forefront. 2023.
2022
Navkiran Randhawa, Ahamed Khalyfa, Rida Aslam, M. Christopher Roebuck, Mahnoor Inam, Kamran Ayub. Endoscopic Ultrasound-Guided Botox Injection for Refractory Anal Fissure. Journal of Clinical Medicine. 2022.
Roebuck,M.. Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update. American Journal of Managed Care. 2022.
Navkiran Randhawa, Ahamed Khalyfa, Mahnoor Khan, Christopher Roebuck, Mahnoor Inam, Kamran Ayub. Utilization of Antireflux Mucosectomy and Resection and Plication. Journal of Clinical Medicine. 2022.
2021
Tufia Haddad, Jane M Helgeson, Katharine E Pomerleau, Anita M Preininger, M Christopher Roebuck, Irene Dankwa-Mullan, Gretchen Purcell Jackson, Matthew P Goetz. Accuracy of an Artificial Intelligence System for Cancer Clinical Trial Eligibility: Retrospective Pilot Study. JMIR Medical Informatics. 2021.
Irene Dankwa-Mullan, Judy George, M. Christopher Roebuck, Joseph Tkacz, Van C Willis, Fredy Reyes, Yull E. Arriaga. Variations in Breast Cancer Surgical Treatment and Timing: Determinants and Disparities. Breast Cancer Research and Treatment. 2021.
2020
J. Thaddeus Beck, Melissa Rammage, Gretchen P. Jackson, Anita M. Preininger, Irene Dankwa-Mullan, M. Christopher Roebuck, Adam Torres, Helen Holtzen, Sadie E. Coverdill, M. Paul Williamson, Quincy Chau, Kyu Rhee, Michael Vinegra. Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center. JCO Clinical Cancer Informatics. 2020.
Peng-ju Chen, Tian-le Li, Ting-ting Sun, Van C. Willis, M. Christopher Roebuck, Dena M. Bravata, Xin-zhi Liu, Yull E. Arriaga, Irene Dankwa-Mullan, Ai-wen Wu. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival. Diseases of the Colon & Rectum. 2020.
Fengrui Xu, Martín-J. Sepúlveda, Zefei Jiang, Haibo Wang, Jianbin Li, Zhenzhen Liu, Yongmei Yin, M. Christopher Roebuck, Edward H. Shortliffe, Min Yan, Yuhua Song, Cuizhi Geng, Jinhai Tang, Gretchen Purcell Jackson, Anita M. Preininger, Kyu Rhee. Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer. JCO Clinical Cancer Informatics. 2020.
2019
Fengrui Xu, Martín-José Sepúlveda, Zefei Jiang, Haibo Wang, Jianbin Li, Yongmei Yin, Zhenzhen Liu, M. Christopher Roebuck, Edward H. Shortliffe, Min Yan, Yuhua Song, Cuizhi Geng, Jinhai Tang, Kyu Rhee. Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise. JCO Clinical Cancer Informatics. 2019.
M. Christopher Roebuck, Joshua N. Liberman. Assessing the Burden of Illness of Chronic Hepatitis C and Impact of Direct-Acting Antiviral Use on Healthcare Costs in Medicaid. American Journal of Managed Care. 2019.
2018
2016
2015
2014
M. Christopher Roebuck. Medical Cost Offsets from Prescription Drug Utilization Among Medicare Beneficiaries. Journal of Managed Care Pharmacy. 2014.
2013
Paul Fronstin, Martín J. Sepúlveda, M. Christopher Roebuck. Consumer-Directed Health Plans Reduce The Long-Term Use Of Outpatient Physician Visits And Prescription Drugs. Health Affairs. 2013.
Paul Fronstin, Martin Sepulveda, M. Christopher Roebuck. Medication Utilization and Adherence in a Health Savings Account-Eligible Plan. American Journal of Managed Care. 2013.
2012
Jennifer M. Polinski, William H. Shrank, Robert J. Glynn, Haiden A. Huskamp, M. Christopher Roebuck, Sebastian Schneeweiss. Association Between the Part D Coverage Gap and Adverse Health Outcomes. Journal of the American Geriatrics Society. 2012.
Jennifer M. Polinski, William H. Shrank, Robert J. Glynn, Haiden A. Huskamp, M. Christopher Roebuck, Sebastian Schneeweiss. Beneficiaries With Cardiovascular Disease and the Part D Coverage Gap. Circulation: Cardiovascular Quality and Outcomes. 2012.
Kevin D. Frick, M. Christopher Roebuck, Joshua I. Feldstein, Catherine A. McCarty, Lori L. Grover. Health Services Utilization and Cost of Retinitis Pigmentosa. Archives of Ophthalmology. 2012.
Ginger S. Carls, M. Christopher Roebuck, Troyen A. Brennan, Julie A. Slezak, Olga S. Matlin, Teresa B. Gibson. Impact of Medication Adherence on Absenteeism and Short-Term Disability for Five Chronic Diseases. Journal of Occupational and Environmental Medicine. 2012.
Jonathan D Ketcham, Claudio Lucarelli, Eugenio J Miravete, M. Christopher Roebuck. Sinking, Swimming, or Learning to Swim in Medicare Part D. American Economic Review. 2012.
2011
2010
2009
2008
2005
Marlon P Mundt, Michael T French, M Christopher Roebuck, Linda Baier Manwell, Kristen Lawton Barry. Brief Physician Advice for Problem Drinking Among Older Adults: An Economic Analysis of Costs and Benefits. Journal of Studies on Alcohol. 2005.
Christopher A. Powers, Christina M. Meyer, M Christopher Roebuck, Baze Vaziri. Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data. Medical Care. 2005.
2004
M. Christopher Roebuck, Michael T. French, Michael L. Dennis. Adolescent Marijuana Use and School Attendance. Economics of Education Review. 2004.
Michael T. French, M. Christopher Roebuck, A. Thomas McLellan. Cost Estimation When Time and Resources Are Limited: The Brief DATCAP. Journal of Substance Abuse Treatment. 2004.
Michael T. French, M. Christopher Roebuck, Pierre Kébreau Alexandre. To Test or Not To Test: Do Workplace Drug Testing Programs Discourage Employee Drug Use?. Social Science Research. 2004.
2003
M. Christopher Roebuck, Michael T. French, A. Thomas McLellan. DATStats: Results from 85 Studies Using the Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment. 2003.
Michael T. French, M. Christopher Roebuck, Michael L. Dennis, Susan H. Godley, Howard A. Liddle, Frank M. Tims. Outpatient Marijuana Treatment for Adolescents: Economic Evaluation of a Multisite Field Experiment. Evaluation Review. 2003.
Pierre Kébreau Alexandre, M. Christopher Roebuck, Michael T. French, Maryann Barry. The Cost of Residential Addiction Treatment in Public Housing (Safeport). Journal of Substance Abuse Treatment. 2003.
2001
Michael T. French, M. Christopher Roebuck, Pierre Kébreau Alexandre. Illicit Drug Use, Employment, and Labor Force Participation. Southern Economic Journal. 2001.
Using the Drug Abuse Screening Test (DAST-10) to Analyze Health Services Utilization and Cost. Substance Use & Misuse. 2001.
Reports, Issue Briefs & Professional Publications
2024
Expanding Pre-Deductible Coverage on Adherence- FF509. . 2024.
HSAs and Health Services Utilization & Costs- FF506. . 2024.
HSAs Reduce Use of Outpatient Services and Prescription Drugs, Increase Use of Inpatient Services; Overall Spending Unaffected. . 2024.
The Impact of Expanding Pre-Deductible Coverage in HSAEligible Health Plans on Medication Adherence. . 2024.
Value-Based Pricing for Hospital Outpatient Services. EBRI Issue Brief #625. 2024.
2023
Imposing Cost Sharing on Preventive Services Significantly Impacts Expenditures for Eligible Enrollees but Does Not Substantially Reduce Aggregate Employer Health Care Spending: Implications of Braidwood Management Inc. v. Becerra. . 2023.
Location, Location, Location: Spending Differences for Biologic and Biosimilar Medications by Site of Treatment. EBRI Issue Brief #585. 2023.
PAOD Cost Differences by Site of Treatment by State and MSA- FF469. . 2023.
Patient Satisfaction, Health Services Use in Barretts Esophagus. . 2023.
Provider Markups on Biologics Are Doubling Costs for Employers. EBRI Fast Facts #479. 2023.
VBID for Adherence Among Diabetics- FF482. . 2023.
2022
How Do High-Deductible Health Plans Affect Use of Health Care Services and Spending Among Enrollees With Mental Health Disorders?. . 2022.
Impact of Preventive Services Coverage on Spending- FF444. . 2022.
Increased Spending on Mental Health- FF443. . 2022.
Limited Impact of Pre-Deductible Coverage- FF441. . 2022.
Pre-Deductible Coverage for Preventive Services- FF437. . 2022.
Pre-Deductible Coverage of Medications- IB563. . 2022.
Switch to HDHP Lowers Use and Cost Among Mental Health- FF431. . 2022.
The Impact of Expanding Pre-Deductible Coverage in HSAEligible Health Plans on Premiums. . 2022.
Use of Health Care Services for Mental Health Disorders and Spending Trends. EBRI Issue Brief #569. 2022.
2021
Higher Lab Costs, Equivalent Value- FF393. . 2021.
Impact of Copay and Coinsurance- FF376. . 2021.
Location, Location, Location: Cost Differences in Health Care Services by Site of Treatment. EBRI Issue Brief #525. 2021.
Location, Location, Location: Spending Differences for Physician-Administered Outpatient Medications by Site of Treatment. . 2021.
Yull Arriaga, Joseph Tkacz, M Christopher Roebuck, Judy George, Van Willis, Irene Dankwa-mullan. Share Tools Versions . . 2021.
Shifting from HOPDs to POs- FF405. . 2021.
Spending Differences in PAODs by Treatment Site Across MSAs and States- FF408. . 2021.
2020
Irene Dankwa-Mullan, M Christopher Roebuck, Joseph Tkacz, Judy George, Fredy Reyes, Yull Edwin Arriaga. Article Info & Metrics Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. . 2020.
Cost Differences for Oncology Medicines Based on Site of Treatment. EBRI Issue Brief #498. 2020.
Do People Choose Wisely After Satisfying Health Plan Deductibles? Evidence From the Use of Low-Value Health Care Services. . 2020.
Higher Oncology Medicine Costs, Equivalent Value- FF345. . 2020.
HOPD-Infused Oncology Medicines Markup by MSAs and State- FF351. . 2020.
Managing Use of Health Care Services After People Satisfy Their Deductible: What Do Copayments and Coinsurance Do?. . 2020.
Post-Deductible Low Value Services Use- FF373. . 2020.
Judy George, Joseph Tkacz, M. Christopher Roebuck, Fredy Reyes, Yull E. Arriaga, Gretchen P. Jackson, Irene Dankwa-Mullan. Real-World Study of Factors Associated with BCS- Abstract. . 2020.
Trend in Site of Treatment Cost Differences for Oncology Medicines- FF360. . 2020.
Trends and Determinants in Time to Primary Surgical Treatment for Breast Cancer- Abstract. . 2020.
2019
Do Accumulating HSA Balances Affect Use of Health Care Services and Spending?. EBRI Issue Brief #482. 2019.
Do HSAs Affect Use of Health Care Services- FF330. . 2019.
Persistency in High-Cost Health Care Claims: “It’s Where the Spending Is, Stupid”. . 2019.
2018
340B Memorandum- Full. . 2018.
Plan Type, Use of Specialty Medications, and Worker Productivity- IB454. . 2018.
Relationship Between Health Plan Type and Use of Specialty Medications- FF310. . 2018.
Unintended Consequences of the 340B Drug Pricing Program. RxEconomics Memorandum. 2018.
Worker Productivity and Use of Specialty Medications- FF313. . 2018.
2017
Paul Fronstin, M Christopher Roebuck. Health Plan Switching: A Case Study―Implications for Private- and Public-Health-Insurance Exchanges and Increased Health Plan Choice. . 2017.
Paul Fronstin, M. Christopher Roebuck. The Impact of Offering Free Coverage on Enrollment Choice and Risk Selection in an HSA-eligible Health Plan. . 2017.
2016
Impact of Medication Adherence on Hospitalization in Medicaid. ISPOR. 2016.
Poster Session Type: Call for Abstracts Sessions. . 2016.
Paul Fronstin, M Christopher Roebuck. The Impact of an HSA-Eligible Health Plan on Health Care Services Use and Spending by Worker Income. . 2016.
Wellness Programs and Medication Adherence- N37_1. . 2016.
2015
Burden of Illness of HCV in Medicaid- Abstract. . 2015.
Paul Fronstin, M Christopher Roebuck. Financial Incentives and Workplace Wellness-Program Participation. EBRI Issue Brief #412. 2015.
Paul Fronstin, M Christopher Roebuck. Financial Incentives, Workplace Wellness Program Participation, and Utilization of Health Care Services and Spending. . 2015.
2014
CDHP and GDR- N35_3. . 2014.
Cost of Spousal Coverage- FF266. . 2014.
Cost of Spousal Coverage- N35_1. . 2014.
Quality of Health Care After Adopting a Full-Replacement HSA-Eligible Health Plan: A Five-Year Study. EBRI Issue Brief #404. 2014.
Reference Pricing for Health Care Services. EBRI Issue Brief #398. 2014.
2013
Downstream Medical Cost Offsets of Prescription Drug Use- Abstract. . 2013.
Paul Fronstin, M Christopher Roebuck. Health Care Spending after Adopting a Full-Replacement, High-Deductible Health Plan With a Health Savings Account: A Five-Year Study. . 2013.
M. Christopher Roebuck, Robert Kaestner, Eugenio J. Miravete. MEDICAID DRUG REBATES IN MEDICARE PART D LOW-INCOME SUBSIDY: AN ECONOMIC ANALYSIS OF THE PROPOSED POLICY AND ITS IMPLICATIONS FOR MULTIEMPLOYER PLANS. . 2013.
Medicaid Rebates in Part D LIS- Executive Summary. . 2013.
Jennifer M. Polinski, William H. Shrank, Robert J. Glynn, Sebastian Schneeweiss, Haiden A. Huskamp, M. Christopher. Roebuck. Response Letter to Eltonsy and Colleagues. . 2013.
September12, 20102018 • No.• 346 November No. 465 The Impact of Health Status and Use of Health Care Services on Disenrollment From HSA-Eligible Health Plans. . 2013.
2012
Poster Session Type: Call for Abstracts Sessions. . 2012.
2004
OOP Costs for Medicare Part D- Abstract. . 2004.